Clinical Trial Update: Evaluation of Postmortem Pulmonary Interstitial Fibrosis Severity and EGFR Positivity in Covid-19 Pneumonia [NA]

View source ↗

Summary

This completed clinical trial update investigates postmortem findings of pulmonary interstitial fibrosis severity and EGFR positivity in COVID-19 pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Snippet

Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital | Conditions: Pneumonia, Viral, COVID-19 Pneumonia | NA | Status: COMPLETED